A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016
- PMID: 31192309
- PMCID: PMC6540514
- DOI: 10.1177/2381468319852332
A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016
Abstract
Background. There is widespread agreement that both the length and quality of life matter when assessing new technologies and/or models of care in the treatment for cancer patients. Quality of life for partners/carers also matters, particularly for prostate cancer. Purpose. This systematic review aims to provide up-to-date utility values along the prostate cancer care continuum (i.e., from prescreening through to palliative care) for use where future trial-based or modelled economic evaluations cannot collect primary data from men and/or partners. Data Sources. A protocol was developed and registered on the international register of systematic reviews-PROSPERO. Databases searched included EBSCO Information Services (CINAHL, EconLit, Global Health, HEED, MEDLINE Complete, PsycINFO), Cochrane Database of Systematic Reviews, Web of Science, and Embase. Study Selection. Study selection terms included health-related quality of life, prostate cancer, and partners or carers. Data Extraction. The authors identified articles published between 2007 and 2016 that provided health state utility values, with statistical uncertainty, for men with or at risk of prostate cancer and/or their partner/carers. Data Synthesis and Results. Study quality and generalizability of utilities was evaluated and meta-analysis conducted against prespecified criteria. From 906 original articles, 29 recent primary studies met the inclusion/exclusion criteria. We tabulate all the utility values with uncertainty, along with considerable methodological detail and patient population characteristics. Limitations. Utility values pertaining to carers/partners were limited to one study. Conclusions. Studies varied in design, measurement instruments utilized, quality, and generalizability. There is sufficient qualitative and quantitative detail for the reported utility values to be readily incorporated into economic evaluations. More research is needed with carers/partners and with newly developing prostate cancer-specific quality of life tools.
Keywords: carers; economic evaluation; patients; preferences; prostate cancer; quality of life; systematic review; utility values.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?Int J Evid Based Healthc. 2008 Mar;6(1):78-110. doi: 10.1111/j.1744-1609.2007.00098.x. Int J Evid Based Healthc. 2008. PMID: 21631815
-
Digital Education for the Management of Chronic Wounds in Health Care Professionals: Protocol for a Systematic Review by the Digital Health Education Collaboration.JMIR Res Protoc. 2019 Mar 25;8(3):e12488. doi: 10.2196/12488. JMIR Res Protoc. 2019. PMID: 30907743 Free PMC article.
-
A Systematic Literature Review of Health Utility Values in Breast Cancer.Med Decis Making. 2022 Jul;42(5):704-719. doi: 10.1177/0272989X211065471. Epub 2022 Jan 18. Med Decis Making. 2022. PMID: 35042379 Free PMC article.
-
Health-related quality of life in patients with conditions affecting the hand: meta-analysis.Br J Surg. 2024 Apr 3;111(4):znae067. doi: 10.1093/bjs/znae067. Br J Surg. 2024. PMID: 38593043 Free PMC article.
Cited by
-
Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study.JAMA Oncol. 2022 Nov 10;9(1):88-94. doi: 10.1001/jamaoncol.2022.5252. Online ahead of print. JAMA Oncol. 2022. PMID: 36355382 Free PMC article.
-
Utility Values of Health Status in Gastric Cancer: A Systematic Review.Value Health Reg Issues. 2025 Mar;46:101063. doi: 10.1016/j.vhri.2024.101063. Epub 2025 Feb 1. Value Health Reg Issues. 2025. PMID: 39892180
-
Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.BMC Med Res Methodol. 2022 Nov 25;22(1):303. doi: 10.1186/s12874-022-01784-6. BMC Med Res Methodol. 2022. PMID: 36434521 Free PMC article.
-
An integrated multicomponent care model for men affected by prostate cancer: A feasibility study of TrueNTH Australia.Psychooncology. 2021 Sep;30(9):1544-1554. doi: 10.1002/pon.5729. Epub 2021 May 24. Psychooncology. 2021. PMID: 33984175 Free PMC article.
-
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia.Pharmacoeconomics. 2022 Aug;40(8):807-821. doi: 10.1007/s40273-022-01156-4. Epub 2022 Jun 27. Pharmacoeconomics. 2022. PMID: 35761117 Free PMC article. Clinical Trial.
References
-
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2015.
-
- Stiggelbout AM, de Hayes JC. Patient preference for cancer therapy: an overview of measurement approaches. J Clin Oncol. 2001;19(1):220–30. - PubMed
-
- EuroQoL Research Foundation. EQ-5D instruments [cited November 1, 2016]. Available from: https://euroqol.org/eq-5d-instruments/
-
- Assessment of Quality of Life. Available from: https://www.aqol.com.au
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous